Interestingly, CSO, in diabetic wounds, promoted the secretion of pro-resolving IL-10 and TGF-β while significantly downregulating TNF-α and IL-1β protein (Fig. 2A–E) demonstrating that CSO may foster pro-resolving milieu in the wound microenvironment even under diabetic conditions. This evidence concerns the gene IL1B and craniosynostosis.